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1. Introduction 
Anatomical descriptions of anterior cruciate ligament (ACL) can be found in Egyptian 
papyrus scrolls dating back to 3000 BC. Hippocrates (460-370BC) has described knee 
subluxation with ACL injury. Even today, the ACL of the knee joint is still the frequent 
target of trauma, especially in the young and active population (Murray, 2009). Rupture of 
the ACL of knee affects over 175,000 patients a year worldwide (Myer et al., 2004). Such 
injury often results from twisting or turning the knee while landing (e.g. non-contact 
rupture), valgus stress (knock-knee position), or hyperextension directly related to contact or 
collision. (Wu et al., 2010). For unknown reasons, this major knee joint stabilizer fails to heal 
after suture repair, (Murray et al., 2007). Often, other knee structures are directly affected 
when partial or complete ACL injuries occur, impairing knee function (Englund et al., 2009). 
The tibia and femur are more likely to rub against each other, leading to cartilage defects 
and osteoarthritis. While a variety of rehabilitation protocols have been assessed, 
rehabilitation doesn’t insure long-term maintenance of knee function. The clinical decision 
to replace a torn ACL is based on the extent of the damage caused by the injury and 
subsequent functioning of the knee, and the choice of ACL substitute that is grafted is made 
accordingly (e.g. autograft, allograft, synthetic, or potentially, a tissue engineered 
autologous construct). The surgery of the ACL is usually performed several weeks after the 
injury in order to allow the swelling and inflammation to subside, although in some 
countries the surgical intervention can occur within hours or days of the injury. After the 
surgery, physical rehabilitation is necessary to strengthen the surrounding muscles, stabilize 
the knee joint, prevent arthrofibrosis, and restore range of motion. 
1.1 Function of the ACL on the knee joint 
The ACL has both proprioceptive and mechanical functions. It is the first restraint to 
anterior translation of the tibia. The ultimate tensile load and stiffness of the human femur-
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ACL-tibia complex are 2160 + 157 N and 242 + 28 N/mm, respectively (Dargel et al., 2007; 
Woo, 2006). The forces applied on the ACL during normal walking are 303N or less 
(Peterson & Zantop, 2007). The highest loads and strains on the ACL during daily 
function are quadriceps-powered extension of the knee, moving it from approximately 40 
degrees of flexion to full extension (This explains why open kinetic chain exercises are 
avoided during early phases of rehabilitation). Secondly, the ACL forces the tibia to 
internally rotate during anterior tibial translation, indicating that the ACL primarily 
restrains internal rotational moments during anteroposterior translation, (Fukubayashi et 
al., 1982). 
1.2 Compromised healing of the injured ACL 
In contrast with extra-articular knee ligaments (e.g. the collateral ligaments), the healing of 
the intra-articular ACL in vivo is poorly understood. A complete tear of the ACL 
(midsubstance or at the insertion), would not leave a residual structure on which to form a 
scar. However, a partial tear should leave at least a partial template to form a scar. 
Interestingly, even if bleeding occurs after ACL injury, no fibrin-platelet plug is observed to 
form inside the joint, even at the injury site. One possible explanation for this observation is 
that circulating intra-articular plasmin breaks down the fibrin plug as fast as it can form 
(Murray, 2009). Recent work has shown that after trauma to the joint, the production of 
plasmin is upregulated via the increased secretion of urokinase plasminogen activator (Rosc 
et al., 2002). With the additional circulating plasmin, the fibrin network is quickly 
destabilized within the joint environment and no fibrin-platelet plug forms. This premature 
loss of the fibrin-platelet plug would have the significant clinical benefit of preventing 
overall joint scarring and stiffness (arthrofibrosis) and thus maintenance of joint mobility 
after injury. As formation of a fibrin-platelet plug is an essential first step for wound healing 
of musculoskeletal tissue outside the joint, the loss of this fibrin-platelet plug inside the joint 
may be the key mechanism behind the failure of intra-articular tissues to heal (Murray, 
2009).  
However, other possibilities likely also exist. In studies of partial injuries to the ACL in 
either rabbit (Lo et al., in preparation; Heubner et al., in preparation) or sheep models 
(Heard et al., 2011), the response to injury leads to an inflammation. In fact, a partial injury 
to one band of the ACL leads to an initial response not dissimilar to that of the MCL at 3 
weeks post-injury, which then fails to mature and ultimately fails to lead to functional 
repair, possibly due to persistent inflammation (Lo et al., in preparation). Thus, the failure of 
healing (non-union) and laxity observed in the ACL after suture repair may also be 
attributed to the adverse influence of synovial fluid (Murray et al., 2009; Woo et al., 2000), to 
alterations in the cellular metabolism after injury (Amiel et al., 1989), and to intrinsic cell 
deficiencies (Kobayashi et al., 2000). The superior capacity of the MCL to increase its blood 
supply through angiogenesis and increased flow is essential for ligament healing to occur, 
and may be the major difference in healing potential between the ACL and MCL (Kobayashi 
et al, 2000). Several growth factors have been studied in tendons post-surgery. The 
expression of Aggrecan, Versican, Biglycan, Lumican, Decorin, TGF-β and β-FGF mRNAs 
have been monitored in vivo, using a rabbit model of flexor tendon injury (Berglund et al., 
2006). The role and the mode of interactions between these various factors, as well as the 
sequential post-traumatic modulation of their expression remain to be defined. However, it 
is clear that whatever the mechanisms involved, the intra-articular environment is not 
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conducive to normal ACL healing, and this also has implications for the incorporation of 
ACL reconstructions with either natural tissues or tissue engineered tissues. 
1.3 Impact of torn ACL on the knee strength, stability and osteoarthritis (OA) 
Injury to the anterior cruciate ligament (ACL) is regarded as critical to the physiological 
kinematics of the femoral-tibial joint, with its disruption eventually causing long-term 
functional impairment. Both the initial trauma and the pathologic motion pattern of the 
injured knee may result in primary degenerative lesions of the secondary stabilisers of the 
knee, each of which are associated with the early onset of OA (Von Porat et al., 2004). 
Consequently, there is a wide consensus that young and active patients may profit from 
reconstructing the ACL. Several factors have been identified as significantly influencing the 
biomechanical characteristics and the functional outcome of an ACL reconstructed knee 
joint. These factors are: (1) individual choice of autologous graft material using either 
patellar tendon-bone grafts or quadrupled hamstring tendon grafts, or another type of ACL 
substitute, (2) anatomical bone tunnel placement within the footprints of the native ACL, (3) 
adequate substitute tension after cyclic graft preconditioning, and (4) graft fixation close to 
the joint line using biodegradable graft fixation materials that provide an initial fixation 
strength exceeding those loads commonly expected during rehabilitation. Based on such 
factors, the literature encourages mid- to long-term clinical and functional outcome 
assessments after ACL reconstruction (Dargel et al., 2007). 
At follow-up, patellofemoral OA is associated with higher activity level, meniscal injury, 
extension and flexion deficit, and ACL reconstruction. Although risk factors for 
posttraumatic OA are multifactorial, the primary risk factor that stood out in the study of 
Neuman et al. (2009), was whether a meniscectomy had been performed. Early activity 
modification and neuromuscular knee rehabilitation might also have been related to the low 
prevalence of radiographic knee OA. In patients with ACL injury willing to restrict 
themselves to moderate activity level to avoid re-injury, initial treatment without ACL 
reconstruction should be considered. (Neuman et al., 2009). Interestingly, the incidence of 
OA after an ACL tear appears to be similar whether or not the ACL has been reconstructed 
(Lohmander et al., 2007; Oiestad et al., 2010; Frobell et al., 2011), possibly due to concurrent 
injury to other joint structures at the time of the ACL tear. However, quality of life and a 
return to knee stability is gained by reconstruction, particularly in younger active patients. 
2. Current surgical approaches to restore knee function after ACL injury 
New options for ACL replacement are under development and some clinical studies are in 
progress (Altman et al., 2008; Murray, 2009). One of these options is tissue engineering of a 
tissue replacement, but the majority of reconstructions are performed with autologous or 
allogeneic tissues. By definition, tissue engineering involves a combination of knowledge 
and skills in biology and in biomechanics (Functional Tissue Engineering Conference 
Group, 2008). Such multidisciplinary science has opened the door to the conception and 
fabrication of new biocompatible materials for ACL reconstruction (Woo, 2009). However, 
independently from the type of ACL substitute chosen, successful reconstruction of the ACL 
depends on anatomic placement of a graft ligament substitute (Cole et al., 2000). Strength 
has been and remains a major consideration in the choice of grafts (Frank & Jackson, 1997). 
Accurate tunnel placement minimizes graft excursion and impingement against the roof of 
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the intercondylar notch. This will result in maximum knee stability and motion (Fineberg et 
al., 2000; Steiner et al., 2008).  
2.1 Autologous tendon for torn ACL replacement 
Orthopaedic autograft reconstruction of the ligament often uses a bone-to-bone technique 
for optimal repair (Frank & Jackson, 1997; Paxton et al., 2009). The central part of the patellar 
tendon, including bone fragments from the tibia and the femur, or the hamstring tendons is 
often used as an ACL substitute. Bone-patellar tendon-bone (BPTB) autografts have been 
proclaimed as the "gold standard" in ACL reconstruction (Woo et al., 2006). 
Biomechanically, a 10-mm wide BPTB graft has stiffness and ultimate load values of 210 ± 65 
N/mm and 1784 ± 580 N, respectively (Wilson et al., 1999), which compare well with those 
of the young human femur-ACL-tibia complex (242 ± 28 N/mm and 2160 ± 157 N, 
respectively), (Woo et al., 2006). It also shows the advantage of having bone blocks available 
for graft fixation in the osseous tunnels that leads to better knee stability. Unfortunately, 
ligament creep or laxity is observed post-surgery, adding to the morbidity associated to the 
partial loss of an healthy tendon, knee chronic pain, loss of motion, knee instability, 
quadriceps weakness and patella rupture. The mechanisms by which such grafts lose 
function is not known in detail, but it may involve replacement of the transplanted tissue by 
a scar-like matrix after neovascularization, infiltration of cells from the intraarticular 
environment, and a persistent inflammation as a consequence of the surgery. Thus, many 
orthopedic surgeons conclude that it is clinically highly justified to explore other strategies 
for ACL replacement. 
2.2 Cadaver allograft ACL implantation 
The use of allograft substitutes (ACL taken from cadavers) overcomes the need for 
autologous tissues, avoiding donor site morbidity. However, this approach has deficiencies 
considering the risks of disease transmission, graft rejection, delayed physiologic integration 
and inflammation (Murray, 2009). Allografts are relatively expensive and their availability 
might be limited. Nevertheless, patellar tendons taken from cadavers are still used for 
ruptured ACL replacement, depending on the short- and long-term needs of each patient 
that is treated. Cadaver allografts are readily strong and they are progressively remodelled 
by the cells of the host in situ post-grafting.  
3. Essential factors needed to translate tissue engineering into effective 
treatment modalities 
Over the last fifteen years, tissue engineered ACL substitutes have raised the interest of 
orthopedic surgeons for obvious reasons. The concept of producing a ligament in vitro 
solves the issue of morbidity associated with autologous tendon grafts.  Depending on the 
technological approach developed to reconstruct an ACL in vitro, the availability of tissue-
engineered products widens the spectrum of surgical options and provides a mid- to long-
term solution to prevent knee joint instability. However, the features of a tissue engineered 
ACL depend on the type of biomaterials that compose its scaffold. The potential and the 
functionality of any reconstructed ligament must be assessed in animal models. This is the 
critical step to evaluate the feasibility, the viability and the factors of failure associated with 
all new ACL replacement strategies under development. 
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3.1 Animal models: strengths and limitations 
Rabbit and goat models have been used to assess torn ACL replacement strategies 
(Xerogeanes et al, 1998). The advantage of the rabbit remains the wide choice of antibodies 
and biomarkers commercially available to analyze the various constituents of ACL 
substitutes post-grafting and ex-vivo. The main limitation of this model is its size, and the 
fact that it doesn’t compare with the human knee joint. The goat is larger and the size of its 
knee joint is close to the human structures. This facilitates development of a pre-clinical 
protocol for the implantation of a new type of ACL replacement. However, significant 
differences are observed between the magnitude of force experienced by the goat ACL and 
its anteromedial and posterolateral bundles when compared with the corresponding human 
ACL. Nonetheless, the caprine animal model is widely used for ACL characterization in 
vitro and in vivo (Tischer et al., 2009; Robayo et al, 2011; Tremblay et al, 2011). The most 
challenging preclinical model to study ACL repair is certainly the dog knee joint. As in 
humans, spontaneous ACL injuries are frequently observed in large dog knee joints. The 
medial meniscus is commonly damaged along with the ACL. The canine model also 
involves several other issues, including early OA development after torn ACL injury 
(Murray et al., 2006). For this reason, an ACL substitute tested with success in the canine 
knee joint would certainly indicate serious potential for use in the human knee. As well, 
success in the canine model could also have veterinary implications for prevention of OA 
development in valuable companion, working and show animals. 
3.2 Cell-seeded (stem cells, autologous cell sources) or acellular ACL substitutes?  
There are two groups of cell-seeded ACL substitutes: tissues populated with live cells (e.g. 
BPTB or semitendinous autologous ACL grafts), and grafts containing dead cells (e.g. 
cadavers allografts). In addition to the risks of immune and⁄or inflammatory reaction, 
autologous or allogenic dead cells must be eliminated post-implantation. The cellular debris 
present in a cell-seeded ACL substitute may slow down or delay its colonization and impair 
the growth of host cells that migrate into the grafts from the bone insertion sites towards the 
middle ligament substance. ACL graft vascularization post-implantation might also be 
delayed by the presence of microstructures that are subjected to an ongoing necrosis process 
in the implant. ACL substitutes already populated with live autologous cells that will not be 
rejected by the host have the potential to be quickly regenerated in situ, following 
neovascularization to restore blood supply, as well as reinnervation. 
Interestingly, tissue engineered ACL substitutes can be seeded with live cells before 
implantation to initiate matrix deposition and remodeling in the tissue. This may enhance 
the integration of the implant in situ post-grafting. However, the choice of the cells source 
remains controversial. The use of mesenchymal stem cells (MSC) is an attractive option as 
these cells have a long lifespan and are not fully differentiated, suggesting that they could 
be tolerated from one individual to another. The use of human serum instead of serum of 
animal source, seems to have a direct and a positive effect on the phenotype of human 
synovium-derived mesenchymal stem cells (MSC), (Tateishi et al., 2008). The results of this 
study indicated that human serum (HS) is superior for the culture of human MSCs 
compared with fetal bovine serum (FBS) in terms of cellular expandability, without losing 
chondrogenic or osteogenic differentiation capacity. Coupled with the advantage in 
eliminating the potential risk accompanied with the use of xeno-derived materials, pooled, 
well-characterized HS could be a useful reagent to promote cellular expansion for clinical 
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synovial stem cell-based therapy. Nonetheless, the use of a “universal” human cell 
population for large-scale production of ACL substitutes would be ideal for obvious 
technical and economic reasons (Hart et al., 2005).  Some issues regarding the source of 
autologous cells present the advantage to be non-immunogenic, but their amplification in 
vitro could also involve some risks of phenotypic changes.  
The source of the MSC is also an issue that needs to be addressed for optimal development 
of a functional tissue engineered construct for replaced of a ruptured ACL. MSC have been 
obtained from multiple sources including bone marrow (BM), muscle, synovial membranes 
(SM), and more recently, from synovial fluid (SF) itself (reviewed in Peng & Huard, 2003; 
McGonagle & Jones, 2008; Chanda et al., 2010;  Augello et al., 2010; Fong et al., 2011). Recent 
studies have indicated that SM-derived MSC are effective in generating tissue engineered 
constructs that can serve as articular cartilage  repair tissues (Ando et al., 2007; Shimomura 
et al., 2010), but whether such MSC can also serve as effective cells to generate a replacement 
ACL have not been explored in detail (McGonagle & Jones, 2008). Very recent studies have 
shown that porcine (Ando et al., in preparation) and normal human (Krawetz et al., in 
preparation) SF and SM MSC exhibit very similar properties, so this source may be a 
preferred population in the future for ACL repair constructs. Why such MSC are present in 
the SF is not known, but likely they are there to facilitate repair normal repair of 
microdamage to intraarticular tissues such as cartilage, menisci and ligaments, so they 
exhibit good potential for tissue engineering purposes. 
The use of fibroblasts isolated from skin instead of ACL biopsies to populate tissue-
engineered ACL substitute led to comparable results in the goat knee joint (Tremblay et al., 
2011). The fibroblasts isolated from both sources secrete the same types of collagen (I and 
III), but a skin microbiopsy is more readily harvested than a tissue sample collected under 
arthroscopy from a ruptured ACL in an injured knee joint. Ultimately, acellular ACL 
substitutes made of biodegradable and biocompatible biomaterials remain the safest option. 
However, such substitutes will have to be colonized by cells from the host post-
implantation. Therefore, tissue-engineered acellular ACL substitutes implies a delayed 
remodeling of the graft (Robayo et al., 2011), which may impair its long-term stability in 
situ. Cells seem to play an essential role in the development of such tissue in vitro. 
However, to keep the best of both options, it would be important to proceed in two phases 
to obtain a viable and efficient ACL substitute. The first phase would be based on the use of 
cells to structure and strengthen the ligament scaffold in culture. When strong enough to 
sustain the biomechanical stress in the joint, the ligament could be lyophilized before 
implantation in order to kill the cells initially present in the implant and allow cell 
colonization by the host, being sure that the structure of the scaffold will play its role, and 
thus enhance integration.  
3.3 Biomaterials: synthetic, native or both?  
To facilitate host cell migration, growth, colonization and remodeling of ACL substitutes 
post-implantation, the scaffold of the graft must be porous and entirely biocompatible. The 
graft must be biodegradable and the products generated by this degradation should also be 
readily eliminated through physiological mechanisms. Collagen I is the major and the 
natural component of the native ACL matrix. Therefore, this protein is highly suitable, alone 
or in combination with other biocompatible constituents, to build the scaffold of a tissue-
engineered ACL substitute (Goulet et al., 2004). For example, a collagen-platelet rich plasma 
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(collagen-PRP) bridging scaffold, added in a central ACL defect, can stimulate healing of the 
ACL histologically and biomechanically (Murray et al., 2006; Spindler et al., 2009). Other 
types of tissue-engineered biomaterial scaffolds have been described for their potential as 
ACL replacement alternatives, as long as they can be implanted and sustain the 
biomechanical stress to which they are subjected in vivo (Altman et al., 2008; Sandmann and 
Tischer, 2010). More recently, the concept of anatomic double bundle ACL reconstruction 
has been developed to replace antero-medial and postero-lateral bundles of the ACL. Such 
approach aims at improving the biomechanical functionality of tissue-engineered grafts, 
even when the knee is subjected to rotatory loads (Woo et al., 2006).  
3.4 Role of biomechanical stimulation in generating an effective tissue-engineered 
construct 
The main advantage of including living cells in any tissue-engineered ACL substitute is the 
possibility to stimulate early matrix synthesis and remodelling in the reconstructed tissue in 
vitro. Cyclic stretching is an example of biomechanical stimuli that increase collagen 
synthesis by cells in the tissue, thereby strengthening the resultant scaffold made of aligned 
fibre bundles (Goulet et al., 2000, Kaneko et al., 2009). Thus, the ACL substitute has already 
reached a first step towards matrix synthesis, and the process can continue to progress in 
response to the in vivo strains that are applied to the graft in the post-transplantation 
environment (Goulet et al., 2004).  
3.5 Placement and effective repair of the biomechanical environment  
The anatomic placement of a graft ligament substitute is crucial for its proper integration 
and functional behavior (Cole et al., 2000). As previously mentioned, accurate tunnel 
placement should be performed with respect to the original insertion sites of the torn ACL, 
to limit graft excursion and impingement against the roof of the intercondylar notch, 
(Fineberg et al., 2000;  Steiner et al., 2008). The ACL substitute must be able to resist an initial 
graft tension ranging from 44 to 88 N (Woo et al., 2006). An in vivo study on goats found no 
significant differences in knee kinematics and in situ forces, between high (35 N) and low (5 
N) initial tension at 6 weeks after surgery (Abramowitch et al., 2003). Viscoelastic studies 
have revealed that the tension in the graft can decrease by as much as 50% within a short 
time after fixation because of its stress relaxation behaviour. Variation in outcomes may also 
be influenced by additional variables associated with the individual such as age, sex, 
genetics, obesity, muscle strength, activity, and re-injury. Therefore, a return to joint stability 
and functional state is the main objective of the clinical management of the knee joint 
following ACL injury. A tissue-engineered ACL substitute that could stabilize the joint and 
maintain its functional state post-grafting is certainly needed. However, if the integrity of 
the grafted material is to continue to function and progress in biomechanical properties, 
then likely the intra-articular environment will have to be manipulated to limit surgery-
induced inflammation and promote anabolic conditions. 
4. Tissue engineered ACL substitutes assessed in vivo and under 
development 
Several tissue-engineered ACL substitutes have been proposed in the literature. Cross-
linked bovine collagen fibers, chitosan-based hyaluronan hybrid polymer fibers, alginate-
www.intechopen.com
  
Tissue Engineering for Tissue and Organ Regeneration 
 
170 
based chitosan hybrid polymer fibers, polyglycolic acid scaffolds, silk matrix, and other 
biodegradable scaffolds seeded or not with living cells (Altman et al., 2008). However, 
presently only ligament augmentation devices have been subjected to clinical trials. In 
contrast, many biosynthetic and biological ACL substitutes are being assessed in preclinical 
models. Such is the case with the tissue engineered ACL substitute that was developed 
using bone blocks, type I collagen and autologous cells (Goulet et al., 2004). The scaffold for 
this ACL substitute is made of bovine type I collagen that is seeded with autologous 
fibroblasts isolated from the ACL of the goat to be grafted. This ligament is produced 
entirely in vitro (Fig.1).   
 
 
Fig. 1. Steps of production of a tissue engineered ACL substitute 
A type I collagen solution (1 mg/ml),  is mixed with autologous fibroblasts (0,5 x 106 cells 
⁄ml) in a test tube containing two bone plugs fixed with a pin at the top and at the bottom of 
it. The collagen polymerizes and is contracted by the cells to obtain a ligament that can be 
used as an in vitro model. To produce a ligament for implantation into a knee joint, a 
surgical thread is placed between the bones (not shown). A lyophilization step is then added 
to obtain a scaffold that is stronger. Once rehydrated, a second layer of collagen including 
cells is subsequently added to the construct. The collagen polymerizes and the ACL 
substitute is ready to be grafted into a knee joint. 
The ACL substitute is maintained under static tension in culture (Fig.2), with the tension 
applied by pulling one of the bone plugs in a programmed manner. This process also 
induces the alignment of the collagen fibers in the direction of the applied tension. 
 
 
Fig. 2. Tissue engineered ACL substitute 
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Macroscopic view of a tissue-engineered ACL substitute maintained in culture for two 
months under static tension, anchored with two spongious bone plugs. Note the central 
portion of the tissue that was contracted by the live cells that populate its type I collagen 
scaffold. A surgical thread, bioresorbed within a month in vivo, reinforces the links between 
the bones.  
The main features that orthopedic surgeons want to know regarding such ACL substitutes 
produced in vitro are their strength and their stiffness. Rupture assays were performed to 
evaluate the mechanical properties of the engineered ligament constructs before 
implantation (Table 1). Any natural collagen gel that is not reinforced using a thread or 
another type of support cannot resist a tension that is higher than 0.5 N (Fig3A). Once 
lyophilized, the collagen scaffold shows an ultimate strength of 2 N (Fig.3B), while the 
addition of a bioresorbed surgical thread will allow the structure to resist a tensile load of 
more than 60 N. 
 
Structure of the matrix Ultimate strength (N) 
Location of the 
rupture site 
1 layer of hydrated 
collagen (gel) 
0.2-0.5 (+ 5%) Interface bone-
ligament 
+ 1 layer of hydrated 
collagen lyophilized 
(rehydrated) 
2 (+ 5%) Middle of the 
ligament 
+ 1 layer of hydrated 
collagen lyophilized 
(rehydrated) around a 
resorbable surgical 
thread: Maxon 3.0) 
> 60N (grafted in goat 
knee joint) 
Not determinated 
Averaged cross-sectional area surface: 100 mm2  (+ 5%) 
N= Newton 
Table 1. Averaged ultimate strength values (n=12) of ex-vivo ACL grafts (n=6) 
The tissue-engineered ACL was grafted into goat knee joints for periods varying from one to 
13 months (Goulet et al., 2004; Robayo et al, 2011; Tremblay et al, 2011). An immobilising 
plaster cast was placed on the leg during the first week post-surgery to limit motion (to 
favour healing) and to prevent the goat from irritating the wound (Fig.4A). Following 
removal of the cast, the goats gradually returned to putting weight on the affected leg, 
walking freely thereafter (Fig.4B).  
Such implant is vascularized within a month in situ post-grafting. Nerve endings, Sharpey’s 
fibers, and fibrocartilage were observed in all of the grafts at six months post-implantation 
(n=3). Electron microscopic analyses demonstrated that the diameter of the collagen fibers 
synthesized by the cells in vivo, were comparable with native ACL fibers (Goulet et al., 
2004). One of the issues that could impede the potential use of this ACL substitute for 
clinical application would be the difficulty to harvest a torn ACL biopsy to isolate the cells 
www.intechopen.com
  
Tissue Engineering for Tissue and Organ Regeneration 
 
172 
that are required. Recently, experiments conducted with tissue engineered ACLs seeded 
with autologous skin fibroblasts and grafted in goat knee joints for six months led to the 
same observations that were made with ACL cells (Fig.5). Thus, animal experimentation 
using skin fibroblasts has also shown promising signs of integration into the goat knee joint 
(Tremblay et al., 2011).  Interestingly, analyses by zymography demonstrated that caprine 
and human fibroblasts, isolated from ACL and skin biopsies, secrete the same types of 
gelatinases (collagenases), suggesting that they share similar potential for collagen 
remodeling (data not shown). 
 
 
Fig. 3. Collagen scaffolds of a tissue engineered ACL subjected to static tension in culture. 
Photomicrographs of histological microsections of the type I collagen scaffold of tissue-
engineered ACL stained with the Trichrome de Masson’s method. Note the good alignment 
of the collagen fibers that was induced by the horizontal tension applied on the tissue for 24 
hrs in culture. Shortly after collagen polymerization, the density of the fibers in the tissue-
engineered scaffold is low (A). After lyophilisation and rehydration of the scaffold, the 
collagen fibers become closer to each other, leading to an increased matrix density and 
strength. (x60) 
 
 
Fig. 4. A goat grafted with an autologous tissue-engineered ACL. 
Photograph of a goat three days (A) and one month (B) after the implantation in the right 
knee joint of a tissue-engineered ACL seeded with autologous fibroblasts. The animal could 
jump and run only one month post-implantation 
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Fig. 5. Implantation of a tissue engineered ACL substitute in a goat knee joint. 
Macroscopic view of a tissue-engineered ACL substitute at the time of implantation (A) and 
six months later (B). The articular cartilage didn’t show any sign of degeneration before and 
after tissue-engineered ACL implantation 
5. Conclusions 
The fundamental and clinical issues associated with the management of torn ACL 
replacement remain those that were described by Frank and Jackson (1997) fifteen years ago. 
Back then, the concept of an effective tissue-engineered ligament for permanent ACL 
replacement was a new and exciting distant possibility. Today, such a concept is a very 
realistic outcome, with the evolution of nanotechnology, combined with a wider spectrum 
of biomaterials developed through interdisciplinary skills and know-how (Functional Tissue 
Engineering Conference Group, 2008). The development of tissue-engineered ACLs in vitro 
presents several advantages for the patients and for the orthopaedic surgeons. It avoids 
healthy tissue morbidity and thus, reduces the period of rehabilitation post-surgery. It 
allows the production of a substitute that has the proper length, diameter and scaffold to fit 
the joint and stabilize it. The modulation of matrix fibers in vitro by mechanical stimulation, 
cell-matrix interactions and structural modifications of the scaffold, are good indicators that 
the tissue-engineered ACL substitute will become a viable surgical option in a very near 
future.  
However, generation of an effective engineered ACL replacement that can withstand the in 
vivo loading environment is only a critical first step in a process. Implantation and post-
implantation events are also critical to sustain the potential of such engineered constructs, 
and these include correct placement of the grafts to mimic normal loading patterns, as well 
as controlling the intraarticular environment of minimize the catabolic influence of 
persistent inflammation and maximizing the anabolic activities in this compartment. Such 
control could contribute to the long-term effectiveness of the constructs via prevention of 
loss of function via alteration of their creep properties and prevention of conversion to a 
structure with scar-like properties. With such control, knee function can be restored and risk 
for OA development later in life may be abrogated. 
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